Ordesa saw turnover grow to €112.4 millions, up 4.7%, in 2014 Blog Post

Laboratorios Ordesa today announced its results for the 2014 year, which reveal a growing trend mainly due to increased sales, cutting structural costs, implementing more efficient sales policies and consolidating foreign markets the company had opened in previous years. Since 2007, the Ordesa Group has a R&D&i center at Barcelona Science Park, from where the company actively participates in clinical studies and national and international research projects in the areas of immunology and cognitive development. The elaboration of hydrolyzed cereals, liquid milk, or the launching of the first porridge with bifidus effect, and supplemented infant formulas are some of the results from these projects. 

AWS Truepower takes part in the WindPower American Wind Energy Association fair Blog Post

One more time, AWS Truepower, one of the world’s leading consultancy firms in the field of renewables energies, is present at the Windpower fair of the American Wind Energy Association (AWEA) that is starting today and will run until Thursday at the Orange County Convention Center in Orlando (Florida). The subsidiary company for Europe and Latin America –AWS Truepower SLU– is based at the Parc Cientific de Barcelona (PCB).

Ordesa leads the Smartfoods project Blog Post

The Centre for the Development of Industrial Technology (CDTI) has granted the Smartfoods industrial research project for the development of smart food to a consortium of companies led by Ordesa from this R&D&i center at Parc Científic de Barcelona.The aim of this research is the design of foods and screening tests that will help reduce the risk of some of the most frequently occurring diseases that will cause 3 of every 4 deaths in 2020.

The Human Protein Atlas will pave the way to personalized medicine Blog Post

World leaders in proteomics are meeting with local doctors and researchers today and tomorrow at CosmoCaixa Barcelona, in an event held by B·Debate, an initiative by Biocat and Obra Social ‘la Caixa’, co-organized in this edition by the Barcelona Science Park (PCB), ProteoRed-ISCIII, Bellvitge Biomedical Research Institute (IDIBELL), Centre for Genomic Regulation (CRG) and Vall d’Hebron Institute of Oncology (VHIO). Four scientists of renowned prestige in this field –including Dr. Eliandre de Oliveira, head of the PCB’s Proteomics Platform– lead this debate.

 

Experience the leading science with its main actors! Blog Post

Getting society closer to science, creating scientific vocation and making interaction easier between the audience and scientists are the main goals of the 15th edition of the Live Research Fair, which will take place in CosmoCaixa Barcelona from the 3rd to the 6th of May. The event is co-organized by the Barcelona Science Park (PCB) and the Obra Social “la Caixa”, with the support from the Barcelona City Council and the Spanish Foundation for Science and Technology (FECYT).

 

Omega-3 fatty acids stimulate brown adipose tissue metabolism Blog Post

Omega-3 fatty acids are able to stimulate the activation of brown and beige adipose tissues, a discovery that would promote the development of new therapies for obesity and other metabolism diseases, according to a research study published in the journal Nature Communications under the supervision of Professor Francesc Villarroya, from the Department of Biochemistry and Molecular Biomedicine and member of the Institute of Biomedicine of the University of Barcelona (IBUB) –located at PCB– and the Biomedical Research Center Red-Fisiopatología de la Obesidad y Nutrición (CIBEROBN) of the Institute of Health Carlos III.

 

The sperm tail may determine semen quality Blog Post

The annual Congress of the European Society of Human Reproduction and Embryology (ESHRE) has been the setting chosen by the Eugin group and the Centre for Genomic Regulation (CRG) to present new collaborative research. The study describes, for the first time, the presence of alterations in the tail of the human sperm, the so called flagellum, which will help indicate the quality of sperm and improve the diagnosis of infertility.

 

Atrian Bakers’s bread Tritordeum, made with the new cereal Agrasys, nominated to the Carrefour Innovation Awards Blog Post

A new type of bread  produced by Atrian Bakers  and made with Tritordeum,  has been nominated for the 2015 Carrefour Innovation Awards. The new type of bread will be subjected to population vote until the 21st of June. Tritordeum cereal is the first man-made cereal without genetic modification suitable for human consumption. Developed in the late 70s by a group of scientists from the Institute for Sustainable Agriculture (IAS) of the Higher Council for Scientific Research (CSIC)), and after 30 years of research, Agrasys -a spin-off company based at the Barcelona Science Park, founded by researchers from the IAS and the industry, launched the new bread to the market in April 2013.